STAT3 and neoplasm: Platinum based drugs temporarily upregulate PD-L1 expression in tumor cells by activating DNA damage response pathways (such as ATM/ATR) and their downstream STAT3/NF - κ B signaling (Sato et al., 2020; Shin et al., 2019).